XML 86 R71.htm IDEA: XBRL DOCUMENT v3.24.1
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Earnings per share [abstract]    
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (8,823,513) $ (13,586,027)
Weighted average number of ordinary shares used in calculating basic earnings per share 239,779,384 145,661,097
Weighted average number of ordinary shares used in calculating diluted earnings per share 239,779,384 145,661,097
Basic earnings per share $ (3.68) $ (9.327)
Diluted earnings per share $ (3.68) $ (9.327)